Background IBD is a chronic inflammatory condition driven by complex genetic and immune interactions, yet preclinical models often fail to fully recapitulate all aspects of the human disease. A ...
AI can improve cancer outcome predictions by generating synthetic molecular data from routine pathology images, according to new research ...
N2OFF, Inc. (NASDAQ: NITO) ('N2OFF” and the 'Company”), a drug discovery company that is also investing in solar energy ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
Illumina launched the Billion Cell Atlas to train AI on one billion single cells. AstraZeneca, Merck and Lilly are founding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback